Brief: Algernon Files Pre-Ind Meeting Request For Ifenprodil Coronavirus Trial With U.S. FDA

Grey Matters Health

13/03/2020 13:06

March 13 (Reuters) - Algernon Pharmaceuticals Inc  AGN.CD :
    * ALGERNON ANNOUNCES FILING OF U.S. FDA PRE-IND MEETING
REQUEST
FOR IFENPRODIL CORONAVIRUS TRIAL, EXPANDED ACCESS, AND EMERGENCY
USE
    * ALGERNON PHARMACEUTICALS INC - REQUEST FOR A PRE-IND
MEETING WAS
ACCOMPANIED BY COMPLETE PRE-IND BRIEFING DOCUMENT
    * ALGERNON PHARMACEUTICALS - FILING INCLUDES CLARIFICATION
OF
EXPANDED ACCESS PATHWAY FOR IFENPRODIL

Source text for Eikon:  ID:nGNX4N1jKS 
Further company coverage:  AGN.CD 

 ((Reuters.Briefs@thomsonreuters.com;))